Recent news highlights mixed fortunes for Goldman Sachs, including potential layoffs due to over-hiring and analyst downgrades impacting companies like Rocket Pharmaceuticals. Read more...

Recent analyst actions affect the stock outlook for Scotts Miracle-Gro (SMG), Titan America (TTAM), and Chipotle Mexican Grill (CMG). Get the latest ratings and target prices. Read more...

Recent analyst reports have adjusted price targets for several stocks, including Fortrea, Docebo, and Silence Therapeutics. We examine these changes and their potential impact. Read more...

StockNews.com has been actively adjusting its ratings for several companies, including upgrades for AXIS Capital and TG Therapeutics, and downgrades for Ferrari and A10 Networks. These changes reflect a dynamic market and evolving analyst perspectives. Read more...

Recent analyst reports have adjusted price targets and ratings for several companies, including Talen Energy, Sunnova Energy, GitLab, Kohl's, and ThredUp. Read more...

William Blair reaffirmed ratings for AvePoint and Biodesix, reiterated a "market perform" for Fortrea, and issued Q1 earnings forecast for Rocket Pharmaceuticals. Read more...

Okta (OKTA) receives multiple analyst upgrades and price target increases from firms like KeyCorp, DA Davidson, Mizuho, and Goldman Sachs, signaling strong market confidence. Read more...